<DOC>
	<DOCNO>NCT00097786</DOCNO>
	<brief_summary>This study test safety effectiveness two drug , one diabetes one hypertension , keep patient high lab value glucose progress frank diabetes develop cardiovascular complication . People study frank diabetes consider `` borderline '' base blood test . People study take none , one drug know one ( ) taking .</brief_summary>
	<brief_title>Long-term Study Nateglinide+Valsartan Prevent Delay Type II Diabetes Mellitus Cardiovascular Complications</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Nateglinide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Adults Impaired glucose tolerance Age dependent risk factor Frank diabetes For detailed information , call contact person .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Prevention</keyword>
	<keyword>Diabetes type 2</keyword>
	<keyword>valsartan</keyword>
	<keyword>nateglinide</keyword>
</DOC>